| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/25/2011 | CA2480684C Host cells having improved cell survival properties and methods to generate such cells |
| 01/25/2011 | CA2428937C Method for treating respiratory distress syndrome using leptin |
| 01/25/2011 | CA2392190C Method of constructing cell-fusion mutants of morbillivirus |
| 01/25/2011 | CA2382931C Synthesis of template-fixed .beta.-hairpin loop mimetics |
| 01/25/2011 | CA2378519C Human cytokine receptor |
| 01/25/2011 | CA2369826C Therapy of cardiac insufficiency |
| 01/25/2011 | CA2356741C Novel rhodococcus bacterium, nitrilase gene, nitryl hydratase gene and amidase gene from rhodococcus bacterium, and process for producing carboxylic acids using them |
| 01/25/2011 | CA2344467C Ucp4 |
| 01/25/2011 | CA2340786C Vaccine comprising cytokine-induced heat shock proteins (hsp) |
| 01/25/2011 | CA2338186C Tumor necrosis factor-gamma |
| 01/25/2011 | CA2321089C Human homolog of the drosophila protein "fused" |
| 01/25/2011 | CA2303509C Modified timp |
| 01/25/2011 | CA2292378C A method of inhibiting cancer cell growth using a vector expressing prb2/p130 |
| 01/25/2011 | CA2281858C A method for making infectious, propagation defective tr339 virus particles and helper cells therefor |
| 01/25/2011 | CA2236378C Recombinant sendai virus |
| 01/25/2011 | CA2199158C Seed-specific promoter from barley beta-amylase gene |
| 01/25/2011 | CA2174098C Method of inducing and maintaining neuronal cells |
| 01/20/2011 | WO2011009036A1 Soybean derived human thyroglobulin, methods of producing and applications thereof |
| 01/20/2011 | WO2011008768A1 Modified egfr ectodomain |
| 01/20/2011 | WO2011008746A2 Serum markers associated with early and other stages of breast cancer |
| 01/20/2011 | WO2011008713A1 Process and system for obtaining botulinum neurotoxin |
| 01/20/2011 | WO2011008641A1 Methids of modulating angiogenesis and treatment of angiogenesis-related diseases |
| 01/20/2011 | WO2011008502A2 Isolation of unknown rearranged t-cell receptors from single cells |
| 01/20/2011 | WO2011008348A2 Dual vector for inhibition of human immunodeficiency virus |
| 01/20/2011 | WO2011008303A2 Designer collagens and uses thereof |
| 01/20/2011 | WO2011008250A1 Modified photoproteins with increased affinity for calcium and enhanced bioluminescence and uses thereof |
| 01/20/2011 | WO2011008096A1 Regulation of zinc deficiency and tolerance in plants |
| 01/20/2011 | WO2011007797A1 Method for measurement of glycoprotein, method for detection of hepatic diseases, reagent for quantification of glycoprotein, and sugar chain marker glycoprotein as measure of disease conditions of hepatic diseases |
| 01/20/2011 | WO2011007773A1 Mutant ras polypeptide crystal |
| 01/20/2011 | WO2011007764A1 Sugar chain marker as measure of disease conditions of hepatic diseases |
| 01/20/2011 | WO2011007747A1 Sugar chain-added ailim extracellular domain and method for producing same |
| 01/20/2011 | WO2011007743A1 Method for specific cleavage of n-cα bond in peptide main chain |
| 01/20/2011 | WO2011007336A1 Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting |
| 01/20/2011 | WO2011007257A1 Detoxified escherichia coli immunogens |
| 01/20/2011 | WO2011007193A1 Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting |
| 01/20/2011 | WO2011007130A1 Therapeutic peptides, polypeptides ans nucleic acid sequences |
| 01/20/2011 | WO2011007004A1 Treatment of infections |
| 01/20/2011 | WO2011006982A2 Inhibitors of complement activation |
| 01/20/2011 | WO2011006966A1 Fermentation of moderately thermophilic bacilli on sucrose |
| 01/20/2011 | WO2011006948A1 Novel fatty acid desaturases and elongases and uses thereof |
| 01/20/2011 | WO2011006891A1 Diagnosis of a parasitic disease such as leishmaniasis using ribosomal protein extract (rpe) |
| 01/20/2011 | WO2011006669A1 Microrna-24 |
| 01/20/2011 | WO2011006497A1 Acylated glucagon analogues |
| 01/20/2011 | WO2011006249A1 Mutated sumo isoforms and uses thereof |
| 01/20/2011 | WO2010117694A3 Citrullinated peptides for diagnosing and prognosing rheumatoid arthritis |
| 01/20/2011 | WO2010109325A3 Combinations including pneumococcal serotype 14 saccharide |
| 01/20/2011 | WO2010095143A3 Cancer cell binding recombinant lectins with antitumor activity and method of preparation |
| 01/20/2011 | WO2010092185A3 Scramblase/cd4 interaction inhibitors for the treatment of lentivirus infections |
| 01/20/2011 | WO2010089757A3 An improved process for synthesis of cyclic octapeptide |
| 01/20/2011 | WO2010081053A3 Transaminase polypeptides |
| 01/20/2011 | WO2010077323A3 Compositions and methods for diagnosing and treating inflammatory bowel disease and related disorders |
| 01/20/2011 | WO2010007441A3 Phosphopeptides and use of the same |
| 01/20/2011 | WO2010002283A9 New insulin analogues of prolonged activity |
| 01/20/2011 | WO2010000374A8 Protein complexes and screening methods |
| 01/20/2011 | WO2003034984A9 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders |
| 01/20/2011 | WO2003024409A3 Q4n2neg2 enhances cftr activity |
| 01/20/2011 | US20110016591 Resistance to auxinic herbicides |
| 01/20/2011 | US20110016579 Gene of transporter selective to mugineic acid-iron complex |
| 01/20/2011 | US20110016578 Soybean variety a1016278 |
| 01/20/2011 | US20110016577 Soybean variety a1016281 |
| 01/20/2011 | US20110016576 Soybean variety a1016279 |
| 01/20/2011 | US20110016575 Soybean variety a1016276 |
| 01/20/2011 | US20110016574 Soybean variety a1016273 |
| 01/20/2011 | US20110016573 Soybean variety a1016268 |
| 01/20/2011 | US20110016572 Soybean variety a1016274 |
| 01/20/2011 | US20110016571 Soybean variety a1016008 |
| 01/20/2011 | US20110016570 Soybean variety a1015460 |
| 01/20/2011 | US20110016569 Soybean variety a1016347 |
| 01/20/2011 | US20110016568 Soybean variety a1015657 |
| 01/20/2011 | US20110016567 Soybean variety a1015862 |
| 01/20/2011 | US20110016566 Soybean variety a1015662 |
| 01/20/2011 | US20110016565 Soybean variety a1015645 |
| 01/20/2011 | US20110016564 Soybean variety a1015646 |
| 01/20/2011 | US20110016563 Soybean variety a1015632 |
| 01/20/2011 | US20110016562 Soybean variety a1015631 |
| 01/20/2011 | US20110016561 Soybean variety a1016240 |
| 01/20/2011 | US20110016560 Soybean variety a1016184 |
| 01/20/2011 | US20110016559 Soybean variety a1016190 |
| 01/20/2011 | US20110016558 Soybean variety a1016131 |
| 01/20/2011 | US20110016557 Soybean variety a1016122 |
| 01/20/2011 | US20110016556 Soybean variety a1016495 |
| 01/20/2011 | US20110016555 Soybean variety a1016115 |
| 01/20/2011 | US20110016554 Soybean variety a1016167 |
| 01/20/2011 | US20110016553 Soybean variety a1016511 |
| 01/20/2011 | US20110016552 Soybean variety a1016082 |
| 01/20/2011 | US20110016548 Control of endogenous dnmt1 gene expression by exogenous binary regulatory systems |
| 01/20/2011 | US20110016538 Susceptibility locus for schizophrenia |
| 01/20/2011 | US20110016537 Cellular model of tauopathies for lead identification and drug discovery |
| 01/20/2011 | US20110015376 Papilloma Virus-Like Particles, Fusion Proteins as Well as Processes for Their Production |
| 01/20/2011 | US20110015375 Methods for Identifying and Using MarR Family Polypeptide Binding Compounds |
| 01/20/2011 | US20110015369 Detection Of Truncation Mutations By Mass Spectrometry |
| 01/20/2011 | US20110015368 Cd4-receptor-derived peptides and method for the preparation thereof |
| 01/20/2011 | US20110015345 Modified FGF-23 Polypeptides and Their Uses |
| 01/20/2011 | US20110015344 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 01/20/2011 | US20110015257 Hypoxia Inducible VEGF Plasmid for Ischemic Disease |
| 01/20/2011 | US20110015131 Methods for preventing and treating alzheimer's disease (ad) |
| 01/20/2011 | US20110015130 Polypeptides Selective for alphavbeta3 Integrin Conjugated With a Variant Of Human Serum Albumin (HSA) And Pharmaceutical Uses Thereof |
| 01/20/2011 | US20110015127 Targeting complement factor h for treatment of diseases |
| 01/20/2011 | US20110015122 Hepatitis b virus-binding polypeptides and methods of use thereof |
| 01/20/2011 | US20110015118 C-Terminal Ifapsoriasin Fragments as Antimicrobial Peptides, the Production Thereof and Use Thereof |